- 4 days & nights inpatient stay
- 1 quick follow-up appointments
Participants will be reimbursed for their participation in this study and this clinical trial has been approved by an independent ethics committee.
About the study
This study is looking at a potential new treatment for epilepsy, a common neurological disorder that affects 3% to 3.5% of Australians. The medication in this study is provided in capsules, which are about the size of multivitamin tablets. Participants will be monitored to assess how the drug is absorbed in the body (how much of the study drug gets into the blood stream and how long the body takes to clear it). It is hoped that the results of this study will then inform further stages of testing in patients who suffer from Epilepsy.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at email@example.com quoting “Prevention Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!